Mytos
Cell Manufacturing
4 open roles Cell Manufacturing London, United Kingdom 42 employees $30M raised Est. 2016
Y Combinator
Buckley Ventures
Wing VC
IQ Capital
ARTIS Ventures
Emles Venture Partners
About Mytos
- Mytos builds fully-automated robotic platforms for manufacturing human cells, specifically stem cell-derived therapies.
- They operate as a CDMO, aiming to scale regenerative medicine from clinical development to commercial production, enabling low-cost access for millions of patients.
Mytos is listed on Rocketlist with 4 active roles. The company is categorized as Cell Manufacturing in BioTech. Mytos is at Series A stage, with a B2B business model, headquartered in London, United Kingdom. Mytos was founded in 2016 and has 42 employees. Mytos has raised $30M. Active roles are refreshed daily from public hiring sources.